Psychemedics Corporation
PMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $13,142 | $16,990 | $27,594 | $38,954 |
| - Cash | $1,417 | $1,964 | $4,750 | $1,992 |
| + Debt | $1,166 | $2,298 | $3,574 | $5,127 |
| Enterprise Value | $12,891 | $17,324 | $26,418 | $42,089 |
| Revenue | $19,685 | $22,098 | $25,240 | $24,909 |
| % Growth | -10.9% | -12.4% | 1.3% | – |
| Gross Profit | $7,101 | $8,413 | $9,291 | $10,264 |
| % Margin | 36.1% | 38.1% | 36.8% | 41.2% |
| EBITDA | $191 | -$751 | $2,233 | $3,899 |
| % Margin | 1% | -3.4% | 8.8% | 15.7% |
| Net Income | -$1,861 | -$4,154 | -$1,084 | -$665 |
| % Margin | -9.5% | -18.8% | -4.3% | -2.7% |
| EPS Diluted | -0.32 | -0.72 | -0.19 | -0.12 |
| % Growth | 55.6% | -278.9% | -58.3% | – |
| Operating Cash Flow | $929 | -$1,480 | $4,890 | $414 |
| Capital Expenditures | -$87 | -$157 | -$187 | -$182 |
| Free Cash Flow | $842 | -$1,637 | $4,703 | $232 |